|
|
1800 Concord Pike, P.O. Box 15437 Wilmington, CA 19850-5437 USA phone:1-302-886-3000 fax:
|
|
| Symbol |
AZN |
| Exchange |
NYSE |
| Founded |
1999 |
| Employees |
|
|
|
| www.astrazeneca-us.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Prescription pharmaceuticals. |
 |
| Management |
| David Brennan, BiographyExecutive Director, Chief Executive Officer; Simon Lowth, Executive Director, Chief Financial Officer; Anders Ekblom, Executive Vice-President, Development; Lynn Tetrault, Executive Vice-President, Human Resources and Corporate Affairs; Bruno Angelici, Executive Vice-President, Europe, Japan, Asia Pacific and ROW |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| gastrointestinal, cardiovascular, cancer, respiratory, neurosciences |
|
|
|
|
|
|
| Description |
|
AstraZeneca PLC, is a research-based pharmaceutical company primarily engaged in providing effective medicines to fight disease in important areas of medical need: cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, and infection. The Company's operations are focused on prescription pharmaceuticals, and more than 97% of its sales are made in that sector. |
 |
 |
|
|
|
|
|
Unable to select database |